Medicaid Drug Rebate Rule Row to Proceed in D.C. Federal Court

Dec. 2, 2021, 2:44 PM

A trade association representing drugmakers can move forward with a lawsuit challenging a new rule for determining drug rebates they must pay to state Medicaid agencies, a federal court in the District of Columbia said.

Materials incorporated by reference into the Pharmaceutical Research & Manufacturers of America’s complaint named several drugmakers and demonstrated how they’ll be harmed by the new rule, the U.S. District Court for the District of Columbia said.

PhRMA didn’t need to specifically name one of its member drugmakers within the “four corners” of the complaint in order to have associational standing to pursue the case on ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.